Church & Dwight Co Inc (CHD)
Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers baking soda, cat litters, laundry detergents, carpet deodorizers, and other baking soda-based products under the ARM & HAMMER brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; dry shampoos under the BATISTE brand; water flossers under the WATERPIK brand; oral care products under the THERABREATH brand; acne treatment products under the HERO brand; hand sanitizers under the TOUCHLAND brand; and condoms, lubricants, and vibrators under the TROJAN brand. It also provides home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; and cold shortening and relief products under the ZICAM brand. In addition, the company's specialty products include animal and food productivity products, such as ARM & HAMMER baking soda as a feed additive to help dairy cow; BIO-CHLOR and FERMENTEN used to reduce health issues associated with calving, as well as needed protein; CELMANAX refined functional carbohydrate, a yeast-based prebiotic; and CERTILLUS a probiotics products used in the poultry, dairy, beef, and swine industries. Additionally, it offers sodium bicarbonate; and cleaning and deodorizing products. The company sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. Church & Dwight Co., Inc. was founded in 1846 and is headquartered in Ewing, New Jersey.
- Symbol
- CHD
- Exchange
- NYSE
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Market cap
- $22.32B
- 52 week range
- 81.33 - 106.04
Valuation
- Share price
- $94.31 (close of 2026-10-02)
- P/E (TTM)
- 30.13x
- Price to book
- 5.13x
- Price to free cash flow
- 20.02x
- Enterprise value
- $24.50B
- Book value per share
- $18.37
Price performance
| Period | Change |
|---|---|
| 1 day | +0.21% |
| 5 days | -2.15% |
| 1 month | -5.04% |
| 3 months | -4.35% |
| 6 months | +1.57% |
| Year to date | +12.47% |
| 1 year | +6.69% |
| 3 years | +2.90% |
| 5 years | +14.68% |
| 10 years | +96.81% |
| All time | +55376.47% |
Members of Congress who disclosed CHD trades
Jonathan Jackson · Lisa McClain · Rick Allen
Super investors holding CHD
Terry Smith (Fundsmith LLP) · Ken Griffin (Citadel) · Ray Dalio (Bridgewater Associates)
Profitability and growth
- Return on equity
- 18.41%
- Return on invested capital
- 14.79%
- Return on assets
- 8.27%
- Return on capital employed
- 14.53%
- Gross margin
- 44.73%
- Net margin
- 11.88%
- EBITDA margin
- 21.36%
- Revenue growth
- 1.57%
- Net income growth
- 25.88%
- Free cash flow growth
- 11.94%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 5.00%
- Current ratio
- 1.15x
- Net debt to EBITDA
- 1.72x
Latest reported year
- Period end
- 2025-12-31
- Fiscal year
- 2025
- Revenue
- $6.20B
- Cost of revenue
- $3.43B
- Gross profit
- $2.77B
- EBITDA
- $1.32B
- Net income
- $736.80M
- Earnings per share
- $3.04
- Research and development
- $145.60M
- Interest expense
- $95.20M
- Shares outstanding
- 242.70M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|---|---|---|---|
| 2025-12-31 | $6.20B | $2.77B | $736.80M | $3.04 |
| 2024-12-31 | $6.11B | $2.79B | $585.30M | $2.39 |
| 2023-12-31 | $5.87B | $2.59B | $755.60M | $3.09 |
| 2022-12-31 | $5.38B | $2.25B | $413.90M | $1.70 |
| 2021-12-31 | $5.19B | $2.26B | $827.50M | $3.38 |
| 2020-12-31 | $4.90B | $2.21B | $785.90M | $3.18 |
| 2019-12-31 | $4.36B | $1.98B | $615.90M | $2.50 |
| 2018-12-31 | $4.15B | $1.84B | $568.60M | $2.32 |
| 2017-12-31 | $3.78B | $1.73B | $743.40M | $2.97 |
| 2016-12-31 | $3.49B | $1.59B | $459.00M | $1.78 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|---|---|---|---|
| 2025-12-31 | 44.73% | 11.88% | 18.41% | 14.79% |
| 2024-12-31 | 45.69% | 9.58% | 13.42% | 11.36% |
| 2023-12-31 | 44.11% | 12.88% | 19.60% | 14.29% |
| 2022-12-31 | 41.86% | 7.70% | 11.86% | 8.29% |
| 2021-12-31 | 43.61% | 15.94% | 25.59% | 14.42% |
| 2020-12-31 | 45.23% | 16.05% | 26.02% | 17.38% |
| 2019-12-31 | 45.53% | 14.13% | 23.09% | 15.22% |
| 2018-12-31 | 44.40% | 13.71% | 23.17% | 14.90% |
| 2017-12-31 | 45.80% | 19.69% | 33.52% | 18.12% |
| 2016-12-31 | 45.54% | 13.14% | 23.21% | 16.40% |
Cash and debt by year
| Period end | Cash | Debt |
|---|---|---|
| 2025-12-31 | $409.00M | $2.21B |
| 2024-12-31 | $964.10M | $2.20B |
| 2023-12-31 | $344.50M | $2.20B |
| 2022-12-31 | $270.30M | $2.60B |
| 2021-12-31 | $240.60M | $2.20B |
| 2020-12-31 | $183.10M | $1.81B |
| 2019-12-31 | $155.70M | $1.81B |
| 2018-12-31 | $316.70M | $1.51B |
| 2017-12-31 | $278.90M | $2.10B |
| 2016-12-31 | $187.80M | $693.40M |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|---|---|
| 2025-12-31 | $1.09B | $58.00M |
| 2024-12-31 | $976.40M | $59.20M |
| 2023-12-31 | $807.10M | $63.60M |
| 2022-12-31 | $706.40M | $32.30M |
| 2021-12-31 | $875.00M | $23.70M |
| 2020-12-31 | $891.40M | $21.50M |
| 2019-12-31 | $790.80M | $20.80M |
| 2018-12-31 | $703.20M | $23.30M |
| 2017-12-31 | $636.50M | $18.10M |
| 2016-12-31 | $605.50M | $16.00M |
Dividend history
- Most recent payment
- 2026-08-14
- Paid in the last twelve months
- $1.22
| Payment date | Dividend per share |
|---|---|
| 2026-08-14 | $0.31 |
| 2026-05-15 | $0.31 |
| 2026-02-13 | $0.31 |
| 2025-11-14 | $0.29 |
| 2025-08-15 | $0.29 |
| 2025-05-15 | $0.29 |
| 2025-02-14 | $0.29 |
| 2024-11-15 | $0.28 |
Investor relations
Next earnings report
- Next confirmed report
- 2026-10-30
- Consensus EPS estimate
- $0.90
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-07-31 | Jun/2026 | $0.89 |
| 2026-05-01 | Mar/2026 | $0.93 |
| 2026-01-30 | Dec/2025 | $0.84 |
| 2025-10-31 | Sep/2025 | $0.73 |
| 2025-08-01 | Jun/2025 | $0.85 |
| 2025-07-31 | - | - |
| 2025-05-01 | Mar/2025 | $0.89 |
| 2025-04-30 | - | - |
Filings and sources
- Company website
- churchdwight.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Clorox Co (CLX) · Kimberly-Clark Corp (KMB) · e.l.f. Beauty, Inc. (ELF) · Kenvue Inc. (KVUE) · Estee Lauder Companies Inc (EL) · Colgate-Palmolive Co (CL) · Kraft Heinz Co (KHC) · General Mills Inc (GIS)
All Consumer Defensive companies
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades